GlassScriptPhysician profile
Lauren Arthur
NPI 1982131959
$372.86
in general payments reported to CMS, 2019-2025
11 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $77.86 · 2024: $164 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molli Surgical (US) INC | $65.48 | 2024 | |
| Medtronic, INC. | $62.38 | 2023-2025 | Transorb, Plasmablade(Tm), Endoflip |
| Tela Bio, INC. | $56.43 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $32.43 | 2024 | Trunode, Trident Specimen Radiography System |
| Lsi Solutions INC | $29.92 | 2025 | Running Device, Ti-Knot |
| Solventum Corporation | $27.30 | 2024 | V.A.C. Veraflo Cleanse Choice |
| Becton, Dickinson and Company | $23.44 | 2023 | Phasix Mesh |
| Vertex Pharmaceuticals Incorporated | $22.41 | 2025 | |
| Heron Therapeutics, INC. | $19.82 | 2025 | Aponvie |
| Ethicon US, LLC | $19.25 | 2024 | Linx Reflux Management System |
| Kowa Pharmaceuticals America, INC. | $14.00 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.